Healthcare groups await FDA's rule on unique device identification
This article was originally published in Clinica
The US FDA has apparently not yet set a date for a rulemaking on a unique device identification (UDI) system. The system has been on the FDA’s drawing board for five years now and, most recently, a coalition of US healthcare groups told the FDA not to delay issuing a rulemaking any longer. Today, when asked for a date for the rulemaking, the FDA told Clinica that “there is specific timeline for this rule”.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.